Board Meeting26 May 2026, 01:43 pm
Vanta Bioscience Board Meeting on May 30, 2026
AI Summary
Vanta Bioscience Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the Standalone and Consolidated Audited Financial Results for the half year and financial year ended March 31, 2026. The board will also review the Audit Reports issued by the Statutory Auditors. The Trading Window remains closed from April 01, 2026, until June 1, 2026, for designated persons as per the Insider Trading Policy.
Key Highlights
- Board meeting scheduled for May 30, 2026, to approve financial results.
- Standalone and Consolidated Audited Financial Results to be considered.
- Audit Reports issued by Statutory Auditors will be reviewed.
- Trading Window closed from April 1 to June 1, 2026.
Price Impact
More from VANTABIO